Treatment outcomes and comparative survival analysis of intraductal carcinoma of the prostate.

Int Urol Nephrol · 2025 · PMC12464113 · PMID 40186732

Europe PMC DOI

hedged sentence

0.0650

closest p · 1.3× alpha

0.0650

boldest claim

The sentences

approached significancep = 0.065so close (0.05 < p ≤ 0.1)

Those with distant disease fared worse among all analyses, while patients with local disease did see improved survival (this only approached significance for 5-year OS: HR = 0.66, p = 0.065).

also in 8,237 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.